Pharmaceutical

Kura Oncology partners Kyowa Kirin to advance AML treatment

Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML

Nov 21, 2024 - 06:00
Kura Oncology partners Kyowa Kirin to advance AML treatment
Kura has partnered Kyowa Kirin in a strategic global collaboration for developing and commercialising oral ziftomenib to treat AML
Read the original article

Tags:

Previous Article

Roche Partners with Transcription Factor Pioneer Flare in over $1.8B Cancer Deal

Next Article

EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: OTC naloxone is a baby step toward making the life-saving medication accessible

Opinion: OTC naloxone is a baby step toward making the ...

Apr 17, 2023

EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia

EC marketing authorisation granted to Pfizer’s HYMPAVZI...

Nov 21, 2024

STAT+: House committee hearing kicks off potential doctor pay reforms in Medicare

STAT+: House committee hearing kicks off potential doct...

Oct 20, 2023